Journal of Applied Phycology

, Volume 9, Issue 2, pp 107–112 | Cite as

Reproductive and peri- and postnatal evaluation of Spirulina maxima in mice

  • Germán Chamorro
  • Silvia Salazar
  • Luis Favila-Castillo
  • Christopher Steele
  • María Salazar
Article

Abstract

Spirulina maxima, provided by Sosa Texcoco Company (México City), was administered to mice of both sexes in a fertility study, at concentrations of 0, 10, 20 and 30% incorporated into the diet. Males were fed for nine weeks while females, for two weeks, and feeding continued during the mating period and gestation. On the other hand, in a peri- and postnatal study, the alga was given only to females at the same concentrations from day 15 of gestation until day 21 post-partum. Treatments were not associated with any adverse effect on reproductive performance, pregnancy rate, number of corpora lutea, resorptions or number of live or dead fetuses. There was no increase in the number of abnormal pups at caesarean section. Length of gestation, parturition status, and litter values were unaffected by treatment. However, there was a statistically significant reduction in bodyweight and survival rate on postnatal days 0–4 at the high dose group in the peri- and postnatal study. The reproductive performance of F1 generation was normal in all groups. We conclude that S. maxima is not toxic to reproduction.

toxicity evaluation reproductive toxicology single cellproteins Spirulina 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Becker EW (1980) Comparative toxicological studies with algae in India, Thailand and Peru. In Shelef G, Soeder CJ (eds), Algae Biomass. Production and Use. Elsevier/North-Holland, Amsterdam, 767–786; 565–574.Google Scholar
  2. Becker EW (1995) Microalgae. Biotechnology and Microbiology. Cambridge University Press, Cambridge, 293 pp.Google Scholar
  3. Belay A, Toshimitsu K, Yoshimichi O (1997) Spirulina (Arthospira): potential application as an animal feed supplement. J. appl. Phycol. 18: 303–311.Google Scholar
  4. Belay A, Yoshimichi O, Kayuzuki M, Shimamatsu H (1993) Current knowledge on potential health benefits of Spirulina. J. appl. Phycol. 5: 235–241.CrossRefGoogle Scholar
  5. Chamorro G, Herrera G, Salazar M, Salazar S, Ulloa V (1988) Subchronic toxicity study in rats fed Spirulina. J. Pharm. Belg. 43: 29–36.PubMedGoogle Scholar
  6. Chamorro GA, Morelos E, Salazar S, Hong E, Salazar M (1995) Evaluation of the teratological potential of the new antihypertensive 5-methoxytryptamine, β-methylcarboxylate hydrochloride (indorenate), in mice. Arch. Med. Res. 26: 69–73.PubMedGoogle Scholar
  7. Chamorro G, Salazar M (1990) Estudio teratogénico de Spirulina en ratón. Arch. Latinoam. Nutr. 86–90.Google Scholar
  8. Chamorro G, Salazar M, Pages N (1996) Dominant lethal study of Spirulina maxima in male and female rats after short-term feeding. Phytother. Res. 10: 28–32.CrossRefGoogle Scholar
  9. Dillon JC, Phan PA. (1993) Spirulina as a source of proteins in human nutrition. Bull. Inst. Ocean. 12: 103–107.Google Scholar
  10. Guideline on detection of toxicity to reproduction for medicinal products. 1993. ICH harmonised tripartite guideline. Endorsed by ICH Steering Committee, June 1993, Washington D.C.Google Scholar
  11. IUPAC. International Union of Pure and Applied Chemistry. 1974. Proposed guidelines for testing of single cell protein destined as a major protein source for animal feed. Information Bulletin. Technical Report No. 12, IUPAC Secretariat. Oxford.Google Scholar
  12. Krishnakumari MK, Ramesh HP, Venkataraman L (1982) Food safety evaluation: acute, oral and dermal effects of the algae Scenedesmus acutus and Spirulina platensis on albino rats. J. Food Protect. 44: 934–935.Google Scholar
  13. Pabst W, Payer HD, Rolle I, Soeder C (1978) Safety evaluation of the microalga, Scenedesmus acutus. I. Biological and haematological data from multigeneration feeding studies in mice. Arch. Hydrobiol. Limnol. 11: 127–138.Google Scholar
  14. PAG. Protein Advisory Group of the United Nations Systems (1974) PAG-Guidelines No. 6 for Clinical Testing of Novel Sources of Protein: PAG Bulletin 4. United Nations, New York, 17–31.Google Scholar
  15. Salazar M, Chamorro GA, Salazar S, Steele CE (1996) Effect of Spirulina maxima consumption on reproduction and peri-and postnatal development in rats. Food Chem. Toxicol. 34: 353–359.PubMedCrossRefGoogle Scholar
  16. Santillán C (1982) Mass production of Spirulina. Experientia 38: 40–43.CrossRefGoogle Scholar
  17. Staples RE, Schnell VL (1964) Refinements in rapid clearing technique in the KOH-alizarin red S method for fetal bone. Stain Technol. 39: 61–63.PubMedGoogle Scholar
  18. Steele CE, Copping GP (1990) Teratogen testing. In Coop AJ, Cockroft DL (eds), Postimplantation mammaliam embryos. A practical approach IRL Press at Oxford University Press, Oxford, 221–234.Google Scholar
  19. Tranquille N, Emeis JJ, de Chambure D, Binot R, Tamponnet C (1994) Spirulina acceptability trials in rats. A study for the ‘Melissa’ life-support system. Adv. Space Res. 14: 1167–1170.CrossRefGoogle Scholar
  20. Tyl RW (1988) Developmental toxicity in toxicologic research. In Ballantyne B(ed.), Perspectives in Basic and Applied Toxicology. Wright, London, 206–241.Google Scholar
  21. Wilson JC (1965) Embryological considerations in teratology. In Wilson JG, Warkany J (eds), Teratology: Principles and Techniques. The University of Chicago Press. Chicago, 251–261.Google Scholar
  22. Yoshino Y, Hirai Y, Takahashi H, Yamamoto N, Yamazaki N (1980) The chronic intoxication test on Spirulina product fed to Wistarstrain rats. Jap. J. Nutr. 38: 221–225.Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • Germán Chamorro
    • 1
  • Silvia Salazar
    • 1
  • Luis Favila-Castillo
    • 2
  • Christopher Steele
    • 3
  • María Salazar
    • 1
  1. 1.Departamento de ToxicologiaMexico
  2. 2.Departamento de Inmunología, Escuela Nacional de Ciencias BiológicasInstituto Politécnico NacionalMéxico D.F.México
  3. 3.Research DepartmentKnoll PharmaceuticalsNottinghamUK

Personalised recommendations